Pharmacological inhibition or siRNA for TRPM7 also reduces migration and invasion in human glioma cells (Leng et al., 2015) and antagonist for TRPM7 reduces various cellular functions such as proliferation, viability, migration, and invasion in both U251/U87 cells (Wong et al., 2020). The gene discussed is TRPM7; the disease is central nervous system cancer.